Intraarterial Chemo + Radiation May Up Cerebral Infarctions

This article originally appeared here.
Share this content:
Intraarterial Chemo + Radiation May Up Cerebral Infarctions
Intraarterial Chemo + Radiation May Up Cerebral Infarctions

MONDAY, April 4, 2016 (HealthDay News) -- Intraarterial chemoradiotherapy (CRT) for head and neck cancer is tied to a higher incidence of cerebral infarction, compared to intravenous CRT, according to a study published online March 25 in Head & Neck.

Sayaka Suzuki, M.D., from the University of Tokyo, and colleagues used the Diagnosis Procedure Combination database (2010 to 2013) to identify patients with head and neck cancer receiving platinum-based chemotherapy and concurrent radiotherapy, either intraarterial or intravenous CRT (propensity score-matched 1:4).

The researchers found that the occurrence of cerebral infarction was significantly higher in the intraarterial CRT group than in the intravenous CRT group (11 of 775 versus 12 of 3,100; P = 0.002). There was no significant difference noted in either mucosal toxicity or febrile neutropenia.

"This result is useful when considering the procedure-related risks and the potential benefits of intraarterial CRT," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters




More in Home

FDA Approves Palynziq for Phenylketonuria

FDA Approves Palynziq for Phenylketonuria

Drug is a novel enzyme therapy for adult patients with PKU with uncontrolled blood Phe concentrations

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in Tx Candidates With 2017 Hypertension Guidelines

Increase in proportion of adults recommended for treatment; estimated decrease in CVD events, deaths